BERKELEY, Calif., July 16, 2007 -- XOMA Ltd. today announced the initiation of Phase I clinical testing of product candidate XOMA 052, a potent monoclonal antibody targeting Interleukin-1 beta , in patients with Type 2 diabetes.
Read More...
[Source: Yahoo! News Search Results for Diabetes for young people]
Why this Blog?
Shortly after my 12 year old nephew was diagnosed with Diabetes 1, I started this blog for he and his mother. There is so much to learn and so much to know and so many unanswered questions. My hope is that it provides a place for knowledge and healing. To your health nephew!
Love Always-
Hannah
Love Always-
Hannah
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment